The remicade biosimilar market is anticipated to grow at a CAGR of 4.5% during the forecast period (2022-2028).Remicade is a branded drugapproved by theFDA which is generally taken in the form of the prescribed medication. It isa chimeric monoclonal antibodyto treat certain autoimmune diseases in adults and children. Whereas remicade biosimilar is defined as a […]
